Abbvie Inc - Global License Agreement to Focus on Development of FG-M701, a Tl1a Antibody, for Treatment of Inflammatory Bowel Disease
AbbVie公司-全球許可協議致力於開發FG-M701,一種用於治療炎症性腸病的Tl1a抗體
Abbvie Inc - Global License Agreement to Focus on Development of FG-M701, a Tl1a Antibody, for Treatment of Inflammatory Bowel Disease
AbbVie公司-全球許可協議致力於開發FG-M701,一種用於治療炎症性腸病的Tl1a抗體
譯文內容由第三人軟體翻譯。